NIFEDIPINE Safety Questions, NIFEDIPINE Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about NIFEDIPINE. Our extensive database of NIFEDIPINE adverse events and NIFEDIPINE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about NIFEDIPINE

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




NIFEDIPINE Safety Reports

Total NIFEDIPINE reports: 190.
NIFEDIPINE FDA safety alerts: No.
Reported deaths: 34    Reported hospitalizations: 84.
Take NIFEDIPINE Side Effects Survey or Share Your NIFEDIPINE Story. NIFEDIPINE Usage.

Showing 1-75 of 190 Next >

Health Professional from UNITED KINGDOM reported NIFEDIPINE problem on July 21, 2006. Female patient, 24 years of age, was diagnosed with tocolysis and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: dizziness, flushing, headache, hypotension, nausea, palpitations, visual disturbance. NIFEDIPINE dosage: unknown. Patient died.

NIFEDIPINE problem was reported by a Health Professional from UNITED STATES on Aug 14, 2006. Female patient, weighting 178.0 lb, was diagnosed with angina pectoris, hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: asthenia, fatigue, visual acuity reduced. NIFEDIPINE dosage: unknown. Patient recovered.

Health Professional from DENMARK reported NIFEDIPINE problem on Aug 09, 2006. Female patient, 24 years of age, was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: hypotension, procedural complication. NIFEDIPINE dosage: 60 MG; QD; PO. Patient died.

NIFEDIPINE problem was reported by a Consumer or non-health professional from DENMARK on July 24, 2006. Female patient, 32 years of age, was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion, premature baby, twin pregnancy. NIFEDIPINE dosage: unknown. During the same period patient was treated with LAMICTAL. Patient was hospitalized. Patient recovered.

Health Professional from KOREA, REPUBLIC OF reported NIFEDIPINE problem on July 25, 2006. Female patient, 63 years of age, was diagnosed with hypertension, diabetes mellitus and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: endometrial disorder, malignant melanoma of sites other than skin, uterine haemorrhage. NIFEDIPINE dosage: 30 MG, ORAL. During the same period patient was treated with METFORMIN, GLICLAZIDE, CILAZAPRIL, ACARBOSE, CARVEDILOL. Patient was hospitalized. Patient recovered.

NIFEDIPINE problem was reported by a Consumer or non-health professional from DENMARK on July 24, 2006. Female patient, 65 years of age, was diagnosed with hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, skin ulcer. NIFEDIPINE dosage: 20 MG; BID; PO. During the same period patient was treated with BENDROFLUAZIDE. Patient was hospitalized. Patient recovered.

Physician from UNITED KINGDOM reported NIFEDIPINE problem on July 30, 2006. Female patient was diagnosed with tocolysis and was treated with NIFEDIPINE. NIFEDIPINE dosage: 30 MG, SINGLE ADMINISTRATION), ORAL; SEE IMAGE. Patient died.

NIFEDIPINE problem was reported by a Health Professional from UNITED KINGDOM on Aug 17, 2006. Female patient, 38 years of age, was diagnosed with tocolysis and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood potassium decreased, chest pain, heart rate increased. NIFEDIPINE dosage: TOTAL DAILY DOSE: 60 MG. During the same period patient was treated with BETAMETHASONE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported NIFEDIPINE problem on Aug 14, 2006. Female patient was diagnosed with tocolysis and was treated with NIFEDIPINE. NIFEDIPINE dosage: 20 MG ORAL. Patient died.

NIFEDIPINE problem was reported by a Health Professional from UNITED STATES on Aug 10, 2006. Female patient, weighting 198.4 lb, was diagnosed with hypertension, spinal osteoarthritis and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, myocardial infarction, tooth disorder, weight decreased. NIFEDIPINE dosage: UNIT DOSE: 60 MG. During the same period patient was treated with MOTRIN, CELEBREX, PERCOCET, CLONIDINE, LISINOPRIL, BUMEX. Patient was hospitalized. Patient recovered.

Health Professional from DENMARK reported NIFEDIPINE problem on Aug 08, 2006. Female patient, 24 years of age, was diagnosed with tocolysis and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: flushing, headache, hypotension, nausea, palpitations, visual disturbance, vomiting. NIFEDIPINE dosage: unknown. Patient died.

NIFEDIPINE problem was reported by a Health Professional from UNITED STATES on Aug 24, 2006. Female patient, weighting 159.0 lb, was diagnosed with angina pectoris and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: chest discomfort, dyspepsia. NIFEDIPINE dosage: 30 MG DAILY PO. Patient recovered.

Consumer or non-health professional from ITALY reported NIFEDIPINE problem on Aug 16, 2006. Female patient, 42 years of age, was diagnosed with pulmonary hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: dyspnoea exertional, fatigue, hypotension, respiratory rate increased. NIFEDIPINE dosage: 60 MG (30 MG, BID), ORAL. During the same period patient was treated with FUROSEMIDE, SPIRONOLACTONE, WARFARIN. Patient was hospitalized. Patient recovered.

NIFEDIPINE problem was reported by a Health Professional from ITALY on Aug 30, 2006. Male patient, 74 years of age, was diagnosed with hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: acantholysis, basal cell carcinoma. NIFEDIPINE dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported NIFEDIPINE problem on Sept 06, 2006. Male patient, 86 years of age, weighting 198.0 lb, was diagnosed with hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: neutropenia, systolic hypertension. NIFEDIPINE dosage: 60MG QD PO. Patient was hospitalized. Patient recovered.

NIFEDIPINE problem was reported by a Physician from ITALY on Aug 24, 2006. Female patient, 42 years of age, was diagnosed with pulmonary hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: dyspnoea exertional, fatigue, hypotension. NIFEDIPINE dosage: 60 MG (30 MG, BID),ORAL. During the same period patient was treated with FUROSEMIDE, SPIRONOLACTONE, WARFARIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from DENMARK reported NIFEDIPINE problem on Aug 28, 2006. Female patient, 38 years of age, was diagnosed with tocolysis and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood potassium decreased, chest pain. NIFEDIPINE dosage: 20 MG Q8H PO. During the same period patient was treated with BETAMETHASONE, NIFEDEPINE SLOW RELEASE. Patient recovered.

NIFEDIPINE problem was reported by a Pharmacist from UNITED STATES on Sept 12, 2006. Male patient was diagnosed with hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: dizziness, orthostatic hypotension. NIFEDIPINE dosage: 60 MG BID PO. During the same period patient was treated with BUMETANIDE, ASPIRIN, ATENOLOL, CALCIUM GLUCONATE, FLUNISOLIDE NASAL, IPRATROPIUM BROMIDE, POTASSIUM CHLORIDE, CLOPIDOGREL. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported NIFEDIPINE problem on July 21, 2006. Female patient, 24 years of age, was diagnosed with tocolysis and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: dizziness, flushing, headache, hypotension, nausea, palpitations, visual disturbance, vomiting. NIFEDIPINE dosage: unknown. Patient was hospitalized. Patient recovered.

NIFEDIPINE problem was reported by a Physician from UNITED STATES on Sept 13, 2006. Female patient was diagnosed with coronary artery disease, hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: dizziness, fatigue. NIFEDIPINE dosage: 30 MG EVERY DAY PO. Patient recovered.

Physician from UNITED KINGDOM reported NIFEDIPINE problem on Sept 01, 2006. Female patient, 38 years of age, was diagnosed with tocolysis and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, chest pain, heart rate irregular, hypotension, palpitations. NIFEDIPINE dosage: 30 MG; X1; PO. During the same period patient was treated with BETAMETHASONE. Patient was hospitalized. Patient recovered.

NIFEDIPINE problem was reported by a Health Professional from ITALY on Sept 04, 2006. Male patient, 74 years of age, was diagnosed with hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: acantholysis, basal cell carcinoma, hyperkeratosis, papilloma. NIFEDIPINE dosage: 10 MG (DAILY),. Patient recovered.

Physician from KOREA, REPUBLIC OF reported NIFEDIPINE problem on Sept 11, 2006. Female patient, 63 years of age, was diagnosed with hypertension, diabetes mellitus and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: endometrial cancer, malignant melanoma of sites other than skin. NIFEDIPINE dosage: 30 MG, ORAL. During the same period patient was treated with METFORMIN, GLICLAZIDE, CILAZAPRIL, ACARBOSE, CARVEDILOL. Patient was hospitalized. Patient recovered.

NIFEDIPINE problem was reported by a Physician from ITALY on Sept 07, 2006. Female patient, 42 years of age, was diagnosed with pulmonary hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: dyspnoea exertional, fatigue, hypotension. NIFEDIPINE dosage: 60 MG (30 MG,BID), ORAL. During the same period patient was treated with FUROSEMIDE, SPIRONOLACTONE, WARFARIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported NIFEDIPINE problem on Sept 22, 2006. Male patient, 54 years of age, weighting 135.0 lb, was diagnosed with hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, constipation, muscle strain, testicular pain. NIFEDIPINE dosage: 60 MG 1X/DAY PO. Patient recovered.

NIFEDIPINE problem was reported by a Pharmacist from UNITED STATES on Sept 25, 2006. Female patient, 31 years of age, weighting 211.0 lb, was diagnosed with raynaud's phenomenon and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: asthenia, dizziness, impaired work ability. NIFEDIPINE dosage: 30 MG 1 Q DAY PO [1 DOSE]. Patient recovered.

Health Professional from JAPAN reported NIFEDIPINE problem on Sept 25, 2006. Male patient, 51 years of age, was diagnosed with intentional overdose and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: circulatory collapse, hypotension, overdose, shock, suicide attempt. NIFEDIPINE dosage: unknown. During the same period patient was treated with IMIDAPRIL HYDROCHLORIDE, DOXAZOSIN MESYLATE, METHYLDOPA, PSYCHOTROPIC AGENTS. Patient was hospitalized. Patient recovered.

NIFEDIPINE problem was reported by a Health Professional from UNITED STATES on July 20, 2006. Female patient, 77 years of age, was diagnosed with hypertension, anxiety and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: anxiety, blood potassium decreased, blood pressure increased, cardiac valve disease, feeling abnormal, heart rate irregular, hypoglycaemia, nervousness. NIFEDIPINE dosage: UNIT DOSE: 60 MG. During the same period patient was treated with LYRICA, KLONOPIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported NIFEDIPINE problem on Sept 12, 2006. Female patient, 77 years of age, was diagnosed with hypertension, anxiety and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: anxiety, blood potassium decreased, blood pressure increased, cardiac valve disease, feeling abnormal, heart rate irregular, hypoglycaemia, nervousness. NIFEDIPINE dosage: 120 MG (60 MG, 2 IN 1 D). During the same period patient was treated with LYRICA, KLONOPIN. Patient recovered.

NIFEDIPINE problem was reported by a Physician from JAPAN on Sept 12, 2006. Female patient, 68 years of age, was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: hyperkeratosis, lichenoid keratosis, lip and/or oral cavity cancer, oral lichen planus, psoriasis, schizophrenia. NIFEDIPINE dosage: 40 MG, ORAL. During the same period patient was treated with LITHIUM CARBONATE, CARDENALIN, ENALAPRIL MALEATE, KESELAN, CHLORPROMAZINE, TASMOLIN, SUNNYASE, AMOBAN. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported NIFEDIPINE problem on Sept 12, 2006. Female patient, 79 years of age, was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: squamous cell carcinoma of skin. NIFEDIPINE dosage: unknown. Patient recovered.

NIFEDIPINE problem was reported by a Physician from ITALY on Sept 13, 2006. Male patient, 74 years of age, was diagnosed with hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: acantholysis, basal cell carcinoma. NIFEDIPINE dosage: 10 MG. Patient recovered.

Health Professional from UNITED KINGDOM reported NIFEDIPINE problem on Sept 15, 2006. Female patient was diagnosed with tocolysis and was treated with NIFEDIPINE. NIFEDIPINE dosage: unknown. Patient died.

NIFEDIPINE problem was reported by a Pharmacist from UNITED KINGDOM on Sept 22, 2006. Female patient, weighting 9.48 lb, was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased. NIFEDIPINE dosage: unknown. Patient recovered.

Health Professional from UNITED KINGDOM reported NIFEDIPINE problem on July 21, 2006. Female patient, 24 years of age, was diagnosed with tocolysis and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: dizziness, flushing, headache, hypotension, nausea, palpitations, visual disturbance, vomiting. NIFEDIPINE dosage: unknown. Patient was hospitalized. Patient recovered.

NIFEDIPINE problem was reported by a Health Professional from UNITED KINGDOM on Aug 17, 2006. Female patient, 38 years of age, was diagnosed with tocolysis and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, chest pain, hypotension, palpitations, pregnancy with contraceptive device. NIFEDIPINE dosage: TOTAL DAILY DOSE: 60 MG. During the same period patient was treated with BETAMETHASONE. Patient was hospitalized. Patient recovered.

Physician from SWEDEN reported NIFEDIPINE problem on Sept 20, 2006. Male patient, 82 years of age, was diagnosed with hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: fall, hypotension, orthostatic intolerance. NIFEDIPINE dosage: unknown. During the same period patient was treated with PLENDIL. Patient was hospitalized. Patient recovered.

NIFEDIPINE problem was reported by a Health Professional from JAPAN on Sept 25, 2006. Male patient, 51 years of age, was diagnosed with intentional overdose and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: hypotension, intentional overdose, shock, suicide attempt. NIFEDIPINE dosage: unknown. During the same period patient was treated with IMIDAPRIL HYDROCHLORIDE, DOXAZOSIN MESYLATE, METHYLDOPA, PSYCHOTROPIC AGENTS. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported NIFEDIPINE problem on Aug 17, 2006. Female patient, 38 years of age, was diagnosed with tocolysis and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood potassium decreased, chest pain, heart rate irregular, hypotension, palpitations. NIFEDIPINE dosage: TOTAL DAILY DOSE: 60 MG. During the same period patient was treated with BETAMETHASONE. Patient was hospitalized. Patient recovered.

NIFEDIPINE problem was reported by a Health Professional from FRANCE on Sept 26, 2006. Male patient was diagnosed with premature labour, streptococcal infection, thrombosis prophylaxis and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: chorioamnionitis, neonatal hypoxia, pulmonary hypertension. NIFEDIPINE dosage: 60 MG. During the same period patient was treated with AMOXICILLIN, LOVENOX, TRACTOCILE, CELESTONE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported NIFEDIPINE problem on Oct 12, 2006. Female patient, 87 years of age, was diagnosed with hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: flushing, supraventricular tachycardia. NIFEDIPINE dosage: 10MG ONCE DAILY PO. Patient was hospitalized. Patient recovered.

NIFEDIPINE problem was reported by a Health Professional from JAPAN on Sept 26, 2006. Female patient was diagnosed with hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, caesarean section, foetal disorder, maternal condition affecting foetus, premature labour. NIFEDIPINE dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from DENMARK reported NIFEDIPINE problem on Sept 26, 2006. Female patient, 24 years of age, was diagnosed with tocolysis and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: flushing, headache, hypotension, nausea, palpitations, visual disturbance, vomiting. NIFEDIPINE dosage: unknown. Patient was hospitalized. Patient died.

NIFEDIPINE problem was reported by a Pharmacist from UNITED KINGDOM on Sept 29, 2006. Female patient, weighting 9.26 lb, was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased. NIFEDIPINE dosage: 1 MG, INTRAVENOUS. Patient recovered.

Consumer or non-health professional from FRANCE reported NIFEDIPINE problem on Oct 02, 2006. Male patient, 53 years of age, was diagnosed with hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: constipation, headache, hepatic calcification, hypertension, pancreatitis, subileus, urinary tract infection enterococcal. NIFEDIPINE dosage: 30 MG, ORAL. During the same period patient was treated with SORAFENIB TOSILATE, AVASTIN, ACEBUTOLOL. Patient was hospitalized. Patient recovered.

NIFEDIPINE problem was reported by a Physician from IRELAND on Oct 05, 2006. Female patient, 14 years of age, was diagnosed with hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, areflexia, circulatory collapse, confusional state, cyanosis, diarrhoea, hallucination, visual, hypotension, muscular weakness. NIFEDIPINE dosage: 40 MG (20 MG, BID),. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported NIFEDIPINE problem on Oct 16, 2006. Male patient, child 3 years of age, was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered. NIFEDIPINE dosage: UNIT DOSE: 60 MG. Patient died.

NIFEDIPINE problem was reported by a Physician from UNITED STATES on Oct 20, 2006. Female patient, weighting 166.0 lb, was diagnosed with hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: palpitations. NIFEDIPINE dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported NIFEDIPINE problem on Oct 10, 2006. Male patient, 66 years of age, was diagnosed with hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: hypokalaemia. NIFEDIPINE dosage: 30 MG ORAL. Patient recovered.

NIFEDIPINE problem was reported by a Physician from UNITED KINGDOM on Oct 11, 2006. Male patient, 66 years of age, was diagnosed with hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: hypokalaemia. NIFEDIPINE dosage: 30 MG, ORAL. During the same period patient was treated with ATENOLOL, SIMVASTATIN. Patient recovered.

Health Professional from SWEDEN reported NIFEDIPINE problem on Oct 06, 2006. Female patient, 59 years of age, was diagnosed with hyperlipidaemia and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: ascites, myalgia, oliguria. NIFEDIPINE dosage: 30 MG ORAL. During the same period patient was treated with SIMVASTATIN. Patient was hospitalized. Patient recovered.

NIFEDIPINE problem was reported by a Physician from UNITED KINGDOM on Oct 08, 2006. Female patient, 38 years of age, was diagnosed with tocolysis and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood potassium decreased, chest pain, heart rate increased, heart rate irregular, off label use, palpitations. NIFEDIPINE dosage: 30 MG (30 MG), ORAL. During the same period patient was treated with BETAMETHASONE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported NIFEDIPINE problem on Sept 14, 1988. Female patient, 54 years of age, was diagnosed with suicide attempt and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: aggression, hypotension, tachycardia. NIFEDIPINE dosage: unknown. Patient recovered.

NIFEDIPINE problem was reported by a Health Professional from CANADA on Oct 10, 2006. Female patient, 38 years of age, was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: gingivitis, stomatitis. NIFEDIPINE dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported NIFEDIPINE problem on Sept 25, 2006. Female patient, 14 years of age, was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, areflexia, bradycardia, circulatory collapse, confusional state, cyanosis, diarrhoea, hallucination, visual, hypotension. NIFEDIPINE dosage: UNIT DOSE: 20 MG. Patient was hospitalized. Patient recovered.

NIFEDIPINE problem was reported by a Health Professional from SWITZERLAND on Oct 12, 2006. Female patient, 59 years of age, was diagnosed with hyperlipidaemia and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: ascites, myalgia, oliguria. NIFEDIPINE dosage: 30 MG, ORAL. During the same period patient was treated with SIMVASTATIN. Patient was hospitalized. Patient recovered.

Physician from CANADA reported NIFEDIPINE problem on Oct 12, 2006. Male patient, 73 years of age, was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: hallucinations, mixed. NIFEDIPINE dosage: 120 MG, ORAL. During the same period patient was treated with ASPIRIN, METOPROLOL TARTRATE, MICARDIS. Patient recovered.

NIFEDIPINE problem was reported by a Health Professional from JAPAN on Oct 15, 2006. Female patient was diagnosed with pregnancy induced hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: caesarean section, maternal condition affecting foetus, premature baby. NIFEDIPINE dosage: 40 MG (20 MG,2 IN 1 D), PLACENTAL. During the same period patient was treated with MAGNESIUM CITRATE. Patient was hospitalized. Patient recovered.

Health Professional from IRELAND reported NIFEDIPINE problem on Oct 16, 2006. Female patient, 14 years of age, was diagnosed with hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: bradycardia, circulatory collapse, cyanosis, diarrhoea, hallucination, visual, paraesthesia, porphyria acute, weight bearing difficulty. NIFEDIPINE dosage: 40 MG (20 MG, TWICE DAILY). During the same period patient was treated with CHLORPROMAZINE, PROPRANOLOL. Patient was hospitalized. Patient recovered.

NIFEDIPINE problem was reported by a Health Professional from UNITED STATES on Oct 20, 2006. Male patient, 66 years of age, was diagnosed with hypertension and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: hypokalaemia. NIFEDIPINE dosage: 30 MG, ORAL. During the same period patient was treated with ATENOLOL, SIMVASTATIN. Patient recovered.

Health Professional from UNITED STATES reported NIFEDIPINE problem on Oct 30, 2006. Female patient, 50 years of age, was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: completed suicide. NIFEDIPINE dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, QUETIAPINE FUMARATE. Patient died.

NIFEDIPINE problem was reported by a Health Professional from UNITED STATES on Oct 30, 2006. Female patient, 19 years of age, was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: completed suicide. NIFEDIPINE dosage: unknown. During the same period patient was treated with SERTRALINE, DULOXETINE. Patient died.

Health Professional from UNITED STATES reported NIFEDIPINE problem on Oct 30, 2006. Female patient, 81 years of age, was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. NIFEDIPINE dosage: unknown. During the same period patient was treated with ATENOLOL, GLYBURIDE. Patient died.

NIFEDIPINE problem was reported by a Health Professional from UNITED STATES on Oct 30, 2006. Male patient, 64 years of age, was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood urea increased, cardiac arrest, dizziness, hypokalaemia, hypotension, sinus arrhythmia, suicide attempt, supraventricular extrasystoles. NIFEDIPINE dosage: unknown. Patient was hospitalized. Patient died.

Health Professional from UNITED STATES reported NIFEDIPINE problem on Oct 24, 2006. Male patient was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest. NIFEDIPINE dosage: 40MG (DAILY)ORAL. Patient was hospitalized. Patient died.

NIFEDIPINE problem was reported by a Health Professional from UNITED STATES on Oct 30, 2006. Male patient, child 2 years of age, was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, blood pressure decreased, bradycardia, cardiac arrest, hyperglycaemia, hypokalaemia, hypotension, respiratory rate increased. NIFEDIPINE dosage: UNIT DOSE: 90 MG. Patient died.

Consumer or non-health professional from UNITED STATES reported NIFEDIPINE problem on Oct 24, 2005. Male patient, child 3 years of age, was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: accidental exposure. NIFEDIPINE dosage: unknown. Patient died.

NIFEDIPINE problem was reported by a Physician from UNITED STATES on Oct 26, 2006. Female patient, 34 years of age, was diagnosed with suicide attempt and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: acidosis, alcohol use, conduction disorder, dysarthria, hyperglycaemia, hypotension, intentional overdose, nausea. NIFEDIPINE dosage: 250 MG, ORAL. During the same period patient was treated with ALCOHOL, LANOXIN. Patient was hospitalized. Patient recovered.

Health Professional from AUSTRALIA reported NIFEDIPINE problem on Oct 26, 2006. Female patient, 18 years of age, was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: overdose. NIFEDIPINE dosage: 50 MG. Patient was hospitalized. Patient recovered.

NIFEDIPINE problem was reported by a Health Professional from LEBANON on Nov 14, 2006. Female patient, 37 years of age, was diagnosed with tocolysis and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: caesarean section, chest x-ray abnormal, dyspnoea, fluid retention, hypoxia, orthopnoea, pulmonary oedema, respiratory alkalosis, sodium retention. NIFEDIPINE dosage: TOTAL DAILY DOSE: 160 MG UNIT DOSE: 40 MG. During the same period patient was treated with BETAMETHASONE BENZOATE, CLARITHROMYCIN. Patient recovered.

Health Professional from TAIWAN, PROVINCE OF CHINA reported NIFEDIPINE problem on Mar 08, 2006. Female patient, 80 years of age, was diagnosed with chest pain and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, faecal incontinence, hyporeflexia, ischaemic stroke, muscle spasticity, muscular weakness, paraesthesia, sensory loss, spinal cord infarction. NIFEDIPINE dosage: unknown. During the same period patient was treated with NITROGLYCERIN. Patient was hospitalized. Patient recovered.

NIFEDIPINE problem was reported by a Physician from LEBANON on Nov 01, 2006. Female patient, 37 years of age, was diagnosed with tocolysis and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: caesarean section, chest x-ray abnormal, fluid retention, premature labour, procedural complication, pulmonary oedema, respiratory alkalosis, sodium retention. NIFEDIPINE dosage: 2 DOSES IN 1 HOUR (20 MG), SUBLINGUAL; SEE IMAGE. During the same period patient was treated with BETAMETHASONE, CLARITHROMYCIN. Patient recovered.

Health Professional from UNITED KINGDOM reported NIFEDIPINE problem on Nov 09, 2006. Male patient, 57 years of age, was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: electrocardiogram poor r-wave progression, flushing, hypotension, overdose, tachycardia. NIFEDIPINE dosage: unknown. During the same period patient was treated with ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

NIFEDIPINE problem was reported by a Physician from UNITED STATES on Nov 06, 2006. Female patient, 19 years of age, was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: completed suicide. NIFEDIPINE dosage: unknown. During the same period patient was treated with SERTRALINE, DULOXETINE HYDROCHLORIDE. Patient died.

Consumer or non-health professional from LEBANON reported NIFEDIPINE problem on Nov 10, 2006. Female patient, 37 years of age, was diagnosed with tocolysis and was treated with NIFEDIPINE. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, caesarean section, ejection fraction decreased, fluid overload, obstetric procedure complication, procedural complication, respiratory alkalosis, sinus tachycardia. NIFEDIPINE dosage: 40MG, 1 IN 6 H, ORAL. During the same period patient was treated with CLARITHROMYCIN, BETAMETHASONE. Patient recovered.

Showing 1-75 of 190 Next >

Ask Our Patient Community about NIFEDIPINE

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)